欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2007, Vol. 12 ›› Issue (1): 47-51.

• 基础研究 • 上一篇    下一篇

缺血预处理减轻心肌缺血再灌注诱导的Na+-K+-ATP 酶异常表达

王德国1, 储岳峰2, 柯永胜2, 杨玉雯1   

  1. 1浙皖南医学院附属弋矶山医院老年心血管科, 2心血管科, 芜湖 241001, 安徽
  • 收稿日期:2006-08-03 修回日期:2007-01-11 出版日期:2007-01-26 发布日期:2020-10-26
  • 通讯作者: 柯永胜,男, 副教授, 硕士生导师, 研究方向:缺血性心脏病。Tel:0553-5739313 E-mail: keyongsheng@medmail.com.cn
  • 作者简介:王德国, 男, 医学硕士, 住院医师, 研究方向:缺血性心脏病。Tel:0553-5739308  E-mail: wangdeguo@medmail.com.cn
  • 基金资助:
    安徽省教育厅自然科学基金(2005KJ299, 2006KJ109); 安徽省自然科学基金(050430707)

Ischemic preconditioning attenuates ischemia-reperfusion-induced abnormality of Na+-K+-ATPase protein expression in hearts

WANG De-guo1, CHU Yue-feng2, KE Yong-sheng2, YANG Yu-wen1   

  1. 1Department of Geriatric Cardiology, 2Department of Cardiology, Yijishan Hospital, Wannan Medical College, Wuhu 241001, Anhui, China
  • Received:2006-08-03 Revised:2007-01-11 Online:2007-01-26 Published:2020-10-26

摘要: 目的: 探讨Na+-K+-ATP 酶在心肌缺血预处理保护机制中的作用。方法: 以前降支结扎30 min后复灌60 min 制备心肌缺血再灌注模型, 连续3 次缺血5 min 再灌注10 min 制备缺血预处理模型。以毛花甙丙抑制Na+-K+-ATP 酶功能, 观察心脏收缩和舒张功能、心肌Na+-K+-ATP 酶功能, 免疫组化法检测Na+-K+-ATP 酶α1 、α2 、α3 及β1 亚基的蛋白表达。结果: 心肌缺血再灌注显著抑制心脏舒缩功能、Na+-K+-ATP 酶活性以及α1 、α2 、α3 及β1 亚基的蛋白原位表达;缺血预处理可减轻心肌缺血再灌注诱导的Na+-K+-ATP 酶异常, 保护心脏功能;毛花甙丙可维持心脏舒缩功能, 但显著抑制Na+-K+-ATP 酶和蛋白表达。结论: 缺血预处理能减轻心肌缺血再灌注诱导的Na+-K+-ATP 酶异常, 抑制Na+-K+-ATP酶功能导致缺血预处理保护作用丧失, 维持Na+-K+-ATP酶功能是缺血预处理心肌保护重要机制之一。

关键词: 缺血预处理, 心肌, Na+-K+-ATP 酶基因表达, 毛花甙丙

Abstract: AIM: To study the role of Na+-K+-ATPase in the protective mechanism of ischemic preconditioning (IP) on myocardial ischemia and reperfusion injury. METHODS: Ligation of anterior descending branch of rat hearts for 30 min (ischemia) and reperfusion for 60 min were for establishing the model of ischemia reperfusion (I R), and 5 min of ischemia and 10min of reperfusion were made for three cycles with a view to preparing IP model.After hemodynamic data were recorded, myocardium sample was processed immediately in order to measure the activity of Na+-K+-ATPase and Ca2+-Mg2+-ATPase and the changes of protein expression of α1, α2,α3 and β1 isoforms of Na+-K+-ATPase. RESULTS: IRreduced cardiac contractile and diastolic function, activityof Na+-K+-ATPase and Ca2+-Mg2+-ATPase, and protein expression of α1, α2, α3 and β1 isoforms of Na+-K+-ATPase.IP attenuated the reduction of cardiac function, the activities and protein expression of Na+-K+-ATPaseα1, α2, α3 and β1-isoforms induced by I R.Digilanid Cabolished the effects of IP on Na+-K+-ATPase. CONCLUSION: The beneficial effects of IP on the prohibition of Na+-K+-ATPase induced by myocardial ischemia and reperfusion were abolished by cardiac glycoside.ProtectingNa+-K+-ATPase may play an important role in the mechanism of IP.

Key words: ischemic preconditioning, myocardium, Na+-K+-ATPase gene expression, digilanid C

中图分类号: